XML 29 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Class A Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Equity (Deficit)
Total Stockholders' Equity (Deficit)
Noncontrolling Interest
Total
Balance at Dec. 31, 2018 $ 1 $ 4 $ 3,655 $ (4,322) $ (662) $ (1,349) $ (2,011)
Balance, shares at Dec. 31, 2018 9,731 44,071          
Net income (loss)   (130) (130) (590) (720)
Stock-based compensation 73,000 73,000 73,000
Stock-based compensation, shares          
Balance at Mar. 30, 2019 $ 1 $ 4 3,728 (4,452) (719) (1,939) (2,658)
Balance, shares at Mar. 30, 2019 9,731 44,071          
Balance at Dec. 31, 2018 $ 1 $ 4 3,655 (4,322) (662) (1,349) (2,011)
Balance, shares at Dec. 31, 2018 9,731 44,071          
Net income (loss)             (8,061)
Accrued distributions            
Balance at Jun. 30, 2019 $ 1 $ 4 10,364 (5,790) 4,579 (7,942) (3,363)
Balance, shares at Jun. 30, 2019 9,827 44,071          
Balance at Mar. 31, 2019 $ 1 $ 4 3,728 (4,452) (719) (1,939) (2,658)
Balance, shares at Mar. 31, 2019 9,731 44,071          
Net income (loss) (1,338) (1,338) (6,003) (7,341)
Stock-based compensation 6,733   6,733   6,733
Stock-based compensation, shares          
Repurchase of stock options     (97)   (97)   (97)
Issuance of common stock
Issuance of common stock, shares 96            
Balance at Jun. 30, 2019 $ 1 $ 4 10,364 (5,790) 4,579 (7,942) (3,363)
Balance, shares at Jun. 30, 2019 9,827 44,071          
Balance at Dec. 31, 2019 $ 2 $ 3 5,990 (8,349) (2,354) (2,378) (4,732)
Balance, shares at Dec. 31, 2019 22,494 31,394          
Net income (loss)       8,835 8,835 11,166 20,001
Stock-based compensation     250   250   250
Stock-based compensation, shares            
Issuance of common stock, shares 3            
Exchange of stock  
Exchange of stock, shares 1,124 (1,124)          
Exercise of warrants     12   12   12
Exercise of warrants, shares 1            
Tax Receivable Agreement liability     (221)   (221)   (221)
Accrued distributions     (196)   (196)   (196)
Impact of transactions affecting NCI     120   120 (120)  
Balance at Mar. 31, 2020 $ 2 $ 3 5,955 486 6,446 8,668 15,114
Balance, shares at Mar. 31, 2020 23,622 30,270          
Balance at Dec. 31, 2019 $ 2 $ 3 5,990 (8,349) (2,354) (2,378) (4,732)
Balance, shares at Dec. 31, 2019 22,494 31,394          
Net income (loss)             14,179
Accrued distributions             (4,523)
Balance at Jun. 30, 2020 $ 4 $ 2 20,584 (1,495) 19,095 (1,626) 17,469
Balance, shares at Jun. 30, 2020 36,468 17,510          
Balance at Mar. 31, 2020 $ 2 $ 3 5,955 486 6,446 8,668 15,114
Balance, shares at Mar. 31, 2020 23,622 30,270          
Net income (loss)       (1,981) (1,981) (3,841) (5,822)
Stock-based compensation     962   962   962
Stock-based compensation, shares            
Issuance of common stock $ 1       1   1
Issuance of common stock, shares 80            
Exchange of stock $ 1 $ (1)          
Exchange of stock, shares 12,760 (12,760)          
Exercise of warrants   11   11   11
Exercise of warrants, shares 1            
Exercise of Stock option     (61)   (61)   (61)
Exercise of Stock option, shares 5            
Tax Receivable Agreement liability     56,857   56,857   56,857
Deferred income taxes     (45,266)   (45,266)   (45,266)
Accrued distributions     (4,327)   (4,327)   (4,327)
Impact of transactions affecting NCI     6,453   6,453 (6,453)
Balance at Jun. 30, 2020 $ 4 $ 2 $ 20,584 $ (1,495) $ 19,095 $ (1,626) $ 17,469
Balance, shares at Jun. 30, 2020 36,468 17,510